286 related articles for article (PubMed ID: 30426591)
21. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
23. Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things.
Dewdney SB; Dancisak AC; Lachance JA; Grendys EC; Dowdy SC; Powell M; Schorge JO
Gynecol Oncol; 2018 Mar; 148(3):439-444. PubMed ID: 29395312
[TBL] [Abstract][Full Text] [Related]
24. Relation between the number of board-certified gynecologic oncologists per hospital and survival of cervical cancer.
Yagi A; Ueda Y; Nakagawa S; Morimoto A; Matsuzaki S; Kobayashi E; Kimura T
J Obstet Gynaecol Res; 2019 Jun; 45(6):1160-1166. PubMed ID: 30843312
[TBL] [Abstract][Full Text] [Related]
25. Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study.
Machida H; Matsuo K; Oba K; Aoki D; Enomoto T; Okamoto A; Katabuchi H; Nagase S; Mandai M; Yaegashi N; Yamagami W; Mikami M
J Gynecol Oncol; 2022 Jan; 33(1):e3. PubMed ID: 34783206
[TBL] [Abstract][Full Text] [Related]
26. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
[TBL] [Abstract][Full Text] [Related]
27. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
[TBL] [Abstract][Full Text] [Related]
28. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
[No Abstract] [Full Text] [Related]
29. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
[TBL] [Abstract][Full Text] [Related]
30. Multiple primary cancers associated with endometrial and ovarian cancers: An analysis based upon the Japan Autopsy Annual Database from 2002 to 2010.
Miki Y; Sugawara Y; Shibahara Y; Tsuji I; Sasano H; Ito K
J Obstet Gynaecol Res; 2019 May; 45(5):1012-1018. PubMed ID: 30734421
[TBL] [Abstract][Full Text] [Related]
31. Risk of Gynecologic Cancer as Second versus First Primary Cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
Jalil NA; Zin AA; Othman NH
Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
[TBL] [Abstract][Full Text] [Related]
33. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
[TBL] [Abstract][Full Text] [Related]
34. Final report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology, on a fact-finding questionnaire on the status of treatment of hereditary breast and ovarian cancer syndrome in Japan.
Satoh T; Takamatsu K; Takeshima N; Kobayashi H; Aoki D; Suzuki N
J Obstet Gynaecol Res; 2017 Sep; 43(9):1377-1380. PubMed ID: 28833906
[TBL] [Abstract][Full Text] [Related]
35. Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.
Li X; Zheng S; Chen S; Qin F; Lau S; Chen Q
Tumour Biol; 2015 Jul; 36(7):4961-6. PubMed ID: 25649977
[TBL] [Abstract][Full Text] [Related]
36. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
[TBL] [Abstract][Full Text] [Related]
37. Synchronous early-stage endometrial and ovarian cancer.
Signorelli M; Fruscio R; Lissoni AA; Pirovano C; Perego P; Mangioni C
Int J Gynaecol Obstet; 2008 Jul; 102(1):34-8. PubMed ID: 18342863
[TBL] [Abstract][Full Text] [Related]
38. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Tan W; Stehman FB; Carter RL
Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer incidence and survival in Korea: 1993-2002.
Chung HH; Jang MJ; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2006; 16(5):1833-8. PubMed ID: 17009979
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer incidence and survival in Korea: 1993-2002.
Chung HH; Hwang SY; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2007; 17(3):595-600. PubMed ID: 17300678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
